Notably, analysis of two different data sets reporting on gene expression profiles in tumours from poor outcome or bad outcome N-myc amplified [70] or non-N-myc amplified [71] neuroblastoma patients indicated statistically significant differences in angiogenesis signalling between these groups [see Additional files 13, 14]. This evidence concerns the gene MYCN and neuroblastoma.